Shuaikang Pan
Overview
Explore the profile of Shuaikang Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, et al.
Mol Cancer
. 2025 Mar;
24(1):61.
PMID: 40025508
Aberrant lipid metabolism is a well-recognized hallmark of cancer. Notably, breast cancer (BC) arises from a lipid-rich microenvironment and depends significantly on lipid metabolic reprogramming to fulfill its developmental requirements....
2.
Jin H, Wan M, Pan S, Wang Z, Wang W, Zhang J, et al.
Curr Gene Ther
. 2025 Feb;
PMID: 39936421
Introduction: The absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) is a hallmark of triple-negative breast cancer (TNBC), which results in...
3.
Hu A, Pan S, He Y, Wang X, Qian D, Li X
Curr Med Chem
. 2025 Jan;
PMID: 39838686
Objective: LGALS3BP exhibits differential expression in various types of tumors. This study aimed to analyze its potential diagnostic and prognostic value in Triple- negative Breast Cancer (TNBC). Methods: We conducted...
4.
Pan S, Wan M, Jin H, Ning R, Zhang J, Han X
BMC Immunol
. 2024 Jul;
25(1):42.
PMID: 38977952
Objective: Triple-Negative Breast Cancer (TNBC) is known for its aggressiveness and treatment challenges due to the absence of ER, PR, and HER2 receptors. Our work emphasizes the prognostic value of...
5.
Hua H, Pan S, Diao H, Cao Y, Qian X, Zhang J
Curr Med Chem
. 2024 Feb;
PMID: 38310395
Background: Long-chain acyl-coenzyme A synthases (ACSLs) are responsible for the catalysis of fatty acids into their corresponding fatty acyl-CoAs. The dysregulation of ACSLs has been increasingly recognized in cancer patients....
6.
Ning R, Pan S, Xiao D, Zheng Y, Zhang J
Am J Cancer Res
. 2023 Jun;
13(5):1845-1862.
PMID: 37293146
Several diseases have been linked to the dysfunction of anoctamins. Anoctamins play a wide range of physiological roles, including cell proliferation, migration, epithelial secretion, and calcium-activated chloride channel activity. However,...
7.
Zhang J, Jin H, Pan S, Han C, Sun Q, Han X
Front Immunol
. 2023 Feb;
14:1073550.
PMID: 36814908
Background: Currently, targeting immune checkpoint molecules holds great promise for triple-negative breast cancer (TNBC). However, the expression landscape of immune checkpoint genes (ICGs) in TNBC remains largely unknown. Method: Herein,...
8.
Sun Q, Du J, Dong J, Pan S, Jin H, Han X, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551589
SRY-box transcription factor 11 (, as a member of the family, is a transcription factor involved in the regulation of specific biological processes and has recently been found to be...
9.
Zhang J, Pan S, Han C, Jin H, Sun Q, Du J, et al.
Biomolecules
. 2022 Nov;
12(11).
PMID: 36358906
Recent breakthroughs in immune checkpoint inhibitors (ICIs) have shown promise in triple-negative breast cancer (TNBC). Due to the intrinsic heterogeneity among TNBC, clinical response to ICIs varies greatly among individuals....
10.
Zhang J, Pan S, Jian C, Hao L, Dong J, Sun Q, et al.
Front Immunol
. 2022 Jan;
12:819405.
PMID: 35069604
Breast cancer (BC) is the most common malignancy among females. Chemotherapy drugs remain the cornerstone of treatment of BC and undergo significant shifts over the past 100 years. The advent...